309 related articles for article (PubMed ID: 15607959)
1. Focus on myeloproliferative diseases and myelodysplastic syndromes.
Van Etten RA; Shannon KM
Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
[No Abstract] [Full Text] [Related]
2. The myelodysplastic/myeloproliferative disorders: the interface.
Bennett JM
Hematol Oncol Clin North Am; 2003 Oct; 17(5):1095-100, v. PubMed ID: 14560776
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes clinical practice guidelines in oncology.
Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
[No Abstract] [Full Text] [Related]
4. Myelodysplastic/myeloproliferative neoplasms.
Cazzola M; Malcovati L; Invernizzi R
Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic and myeloproliferative disorders in children.
Hasle H
Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
[TBL] [Abstract][Full Text] [Related]
6. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.
Wang SA; Hasserjian RP; Loew JM; Sechman EV; Jones D; Hao S; Liu Q; Zhao W; Mehdi M; Galili N; Woda B; Raza A
Leukemia; 2006 Sep; 20(9):1641-4. PubMed ID: 16871284
[No Abstract] [Full Text] [Related]
7. New molecular insights in myelodysplastic and myeloproliferative disorders.
Emanuel PD
Clin Adv Hematol Oncol; 2005 Jun; 3(6):459-60. PubMed ID: 16167021
[No Abstract] [Full Text] [Related]
8. Refractory anemia and the myelodysplastic syndromes.
Lawrence LW
Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
[TBL] [Abstract][Full Text] [Related]
9. The myelodysplastic syndromes and myeloproliferative disorders.
Williams JL
Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelomonocytic leukemia: lost in classification?
Bowen DT
Hematol Oncol; 2005 Mar; 23(1):26-33. PubMed ID: 16149105
[TBL] [Abstract][Full Text] [Related]
11. [Myelodysplastic diseases in childhood].
Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
[TBL] [Abstract][Full Text] [Related]
12. [Chronic myeloproliferative diseases. Diagnosis and therapy].
Lengfelder E; Berger U; Reiter A; Hochhaus A; Hehlmann R
Internist (Berl); 2003 Aug; 44(8):1011-2, 1015-27; quiz 1028-9. PubMed ID: 14671816
[TBL] [Abstract][Full Text] [Related]
13. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
14. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.
Cervera N; Itzykson R; Coppin E; Prebet T; Murati A; Legall S; Vey N; Solary E; Birnbaum D; Gelsi-Boyer V
Am J Hematol; 2014 Jun; 89(6):604-9. PubMed ID: 24595958
[TBL] [Abstract][Full Text] [Related]
15. Oncogene mutation and prognosis in the myelodysplastic syndromes.
Padua RA; West RR
Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
[TBL] [Abstract][Full Text] [Related]
16. Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report.
Pitini V; Arrigo C; Teti D; Barresi G; Righi M; Alo G
Haematologica; 2003 May; 88(5):ECR18. PubMed ID: 12745287
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic/myeloproliferative disorders.
Malcovati L; Cazzola M
Haematologica; 2008 Jan; 93(1):4-6. PubMed ID: 18166777
[No Abstract] [Full Text] [Related]
18. Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: the question is "when?".
Maziarz RT; Mesa RA; Tefferi A
Mayo Clin Proc; 2003 Aug; 78(8):941-3. PubMed ID: 12911040
[No Abstract] [Full Text] [Related]
19. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
Gelsi-Boyer V; Cervera N; Bertucci F; Brecqueville M; Finetti P; Murati A; Arnoulet C; Mozziconacci MJ; Mills KI; Cross NC; Vey N; Birnbaum D
Haematologica; 2013 Apr; 98(4):576-83. PubMed ID: 23065512
[TBL] [Abstract][Full Text] [Related]
20. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
Harada Y; Harada H
Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
